Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing REmote SymPtom mOnitoring and maNagement (RESPONd): Evaluating the Impact on Cancer Patients, System Efficiency, and Economic Outcomes

NCT07024329 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT07024329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07024329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing REmote SymPtom mOnitoring and maNagement (RESPONd): Evaluating the Impact on Cancer Patients, System Efficiency, and Economic Outcomes
Lead sponsor
University of Calgary
Phase
Not applicable
Overall status
Recruiting
Start date
May 16, 2025
Completion date
March 31, 2027
Enrollment
1,055 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cancer